Hepion Pharmaceuticals Inc (HEPA)
1.32
+0.08
(+6.45%)
USD |
NASDAQ |
May 17, 16:00
1.32
0.00 (0.00%)
After-Hours: 20:00
Hepion Pharmaceuticals Shareholders Equity (Quarterly): 7.281M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.281M |
| September 30, 2023 | 16.16M |
| June 30, 2023 | 26.37M |
| March 31, 2023 | 37.15M |
| December 31, 2022 | 49.86M |
| September 30, 2022 | 59.26M |
| June 30, 2022 | 67.32M |
| March 31, 2022 | 86.64M |
| December 31, 2021 | 93.00M |
| September 30, 2021 | 102.64M |
| June 30, 2021 | 110.72M |
| March 31, 2021 | 117.57M |
| December 31, 2020 | 40.52M |
| September 30, 2020 | 12.87M |
| June 30, 2020 | 18.29M |
| March 31, 2020 | 18.77M |
| December 31, 2019 | 15.62M |
| September 30, 2019 | 16.23M |
| June 30, 2019 | 18.03M |
| March 31, 2019 | 0.6455M |
| December 31, 2018 | 1.975M |
| Date | Value |
|---|---|
| September 30, 2018 | 4.654M |
| June 30, 2018 | -0.7515M |
| March 31, 2018 | 3.052M |
| September 30, 2017 | 4.993M |
| June 30, 2017 | 9.058M |
| March 31, 2017 | -0.3854M |
| December 31, 2016 | 5.878M |
| September 30, 2016 | -2.996M |
| June 30, 2016 | 1.318M |
| March 31, 2016 | 1.295M |
| December 31, 2015 | 4.984M |
| September 30, 2015 | -1.361M |
| June 30, 2015 | 3.439M |
| March 31, 2015 | 7.884M |
| December 31, 2014 | 8.604M |
| September 30, 2014 | 0.5399M |
| June 30, 2014 | -2.933M |
| March 31, 2014 | -7.342M |
| December 31, 2013 | -0.4899M |
| September 30, 2013 | -0.3226M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
7.281M
Minimum
Dec 2023
117.57M
Maximum
Mar 2021
48.12M
Average
37.15M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 296.52M |
| Madrigal Pharmaceuticals Inc | 850.76M |
| Galectin Therapeutics Inc | -71.09M |
| Viking Therapeutics Inc | 933.89M |
| 89bio Inc | 510.54M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 18.09M |
| Total Liabilities (Quarterly) | 10.81M |